New York State Common Retirement Fund Portfolio holdings
AUM
$75.2B
1-Year Return
24.38%
This Quarter Return
+4.65%
1 Year Return
+24.38%
3 Year Return
+108.85%
5 Year Return
+192%
10 Year Return
+482.31%
AUM
$74.6B
AUM Growth
+$689M
(+0.93%)
Cap. Flow
-$953M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
32.53%
Holding
3,234
New
57
Increased
643
Reduced
1,082
Closed
59
Top Buys
| 1 |
Boeing
BA
|
+$46M |
| 2 |
CME Group
CME
|
+$29M |
| 3 |
PRMB
Primo Brands Corporation
PRMB
|
+$26.4M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$19.5M |
| 5 |
Evergy
EVRG
|
+$18.3M |
Top Sells
| 1 |
Apple
AAPL
|
+$87M |
| 2 |
CNA Financial
CNA
|
+$54.9M |
| 3 |
UnitedHealth
UNH
|
+$39.2M |
| 4 |
Spotify
SPOT
|
+$28.5M |
| 5 |
Advanced Micro Devices
AMD
|
+$27M |
Sector Composition
| 1 | Technology | 32.54% |
| 2 | Financials | 13.46% |
| 3 | Consumer Discretionary | 11.57% |
| 4 | Healthcare | 10.78% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Dyne Therapeutics
DYN
$1.87B
| $588K | ﹤0.01% |
24,973
| – | – |
|
1827
Kosmos Energy
KOS
$799M
| $588K | ﹤0.01% |
171,852
+6,300
| +4% | +$21.6K |
|
1828
Akero Therapeutics
AKRO
$3.48B
| $585K | ﹤0.01% |
21,013
| – | – |
|
1829
CTS Corp
CTS
$1.23B
| $585K | ﹤0.01% |
11,103
| – | – |
|
1830
Kymera Therapeutics
KYMR
$3.36B
| $585K | ﹤0.01% |
14,549
-1,100
| -7% | -$44.2K |
|
1831
The Greenbrier Companies
GBX
$1.42B
| $583K | ﹤0.01% |
9,558
| – | – |
|
1832
Koppers
KOP
$567M
| $582K | ﹤0.01% |
17,970
+6,300
| +54% | +$204K |
|
1833
Virtus Investment Partners
VRTS
$1.34B
| $580K | ﹤0.01% |
2,628
| – | – |
|
1834
Privia Health
PRVA
$2.8B
| $578K | ﹤0.01% |
29,550
| – | – |
|
1835
Reynolds Consumer Products
REYN
$4.84B
| $577K | ﹤0.01% |
21,376
| – | – |
|
1836
Upwork
UPWK
$2.24B
| $575K | ﹤0.01% |
35,155
| – | – |
|
1837
Arhaus
ARHS
$1.52B
| $573K | ﹤0.01% |
61,005
| – | – |
|
1838
MasterBrand
MBC
$1.71B
| $572K | ﹤0.01% |
39,180
| – | – |
|
1839
Riskified
RSKD
$721M
| $571K | ﹤0.01% |
120,740
+6,487
| +6% | +$30.7K |
|
|
UHT
1840
Universal Health Realty Income Trust
UHT
$575M
| $570K | ﹤0.01% |
15,309
| – | – |
|
1841
Kennametal
KMT
$1.58B
| $566K | ﹤0.01% |
23,573
| – | – |
|
1842
Delek US
DK
$1.68B
| $565K | ﹤0.01% |
30,548
+5,400
| +21% | +$99.9K |
|
1843
DiamondRock Hospitality
DRH
$1.71B
| $565K | ﹤0.01% |
62,574
| – | – |
|
1844
Beam Therapeutics
BEAM
$2.08B
| $564K | ﹤0.01% |
22,729
| – | – |
|
1845
Enliven Therapeutics
ELVN
$1.18B
| $563K | ﹤0.01% |
25,023
-2,488
| -9% | -$56K |
|
1846
Celldex Therapeutics
CLDX
$1.62B
| $562K | ﹤0.01% |
22,237
| – | – |
|
1847
Zynex
ZYXI
$44.8M
| $562K | ﹤0.01% |
70,213
| – | – |
|
|
HTO
1848
H2O America Common Stock
HTO
$1.75B
| $560K | ﹤0.01% |
11,369
| – | – |
|
1849
RPC Inc
RES
$986M
| $558K | ﹤0.01% |
93,901
| – | – |
|
1850
NCR Voyix
VYX
$1.77B
| $558K | ﹤0.01% |
40,298
| – | – |
|